Neonatal hearing test results in the Çukurova region

Abstract

Objective: In this article, we aimed to present the neonatal hearing screening protocol and test results in healthy neonates in Adana City Training and Research Hospital, Adana. Method: A total of 2022 healthy newborns were scanned between November 2018 and February 2019 in our hospital with a three-stage screening protocol. Initial transient evoked otoacoustic emissions (TEOAE), followed by a second stage transient evoked otoacoustic emission and third stage automated auditory brainstem response (A-ABR) were used. If there was a referral with these two methods, clinical BERA was used. High risk newborns were defined. Results: In total, of the 2022 infants included in the study, hearing loss was detected in 34 newborns and the frequency of congenital hearing loss was 1.7%. According to our results, hyperbilirubinemia was more common in infants with hearing loss. Conclusion: Performing hearing screening tests in all newborns, raising public awareness on this issue, and legal follow-up are very important.